Mononuclear Co(III), Ni(II) and Cu(II) complexes of 2‐(2,4‐dichlorobenzamido)‐N'‐(3,5‐di‐tert‐butyl‐2‐hydroxybenzylidene)benzohydrazide: Structural insight and biological assay

A series of mononuclear metal complexes of Co(III), Ni(II) and Cu(II) with 2‐(2,4‐dichlorobenzamido)‐N′‐(3,5‐di‐tert‐butyl‐2‐hydroxybenzylidene)benzohydrazide ( LH ₃ ) have been synthesized and characterized using various physico‐chemical, spectroscopic and single crystal X‐ray diffraction techniques. Structural studies of [Co( LH )( LH ₂ )]·H₂O ( 4 ) revealed the presence of both amido and imidol tautomeric forms of LH ₃ , resulting in a distorted octahedral geometry around the Co(III) ion. [Ni( LH )(H₂O)]·H₂O ( 5 ) and [Cu( LH )(H₂O)]·H₂O ( 6 ) are isomorphous structures and crystallize in the monoclinic P2₁/c space group. The crystal structures of 4 , 5 and 6 are stabilized by hydrogen bonds formed by the enclathrated water molecules, C‐H···π and π···π interactions. Complexes along with the ligand ( LH ₃ ) were screened for their in vivo anti‐inflammatory activity (carrageenan‐induced rat paw edema method) and in vitro antioxidant activity (DPPH free radical scavenging assay). Metal complexes have shown significant anti‐inflammatory and antioxidant potential.     

A 2D Metal‐Organic Framework Based on 9‐(Pyridin‐4‐yl)‐9H‐carbazole‐3,6‐dicarboxylic Acid: Synthesis,Structure and Properties

A metal‐organic framework (MOF ) formulated as [Cd₂(μ₃‐L)₂(DMF )₄]•H₂O ( CdL ) [H₂L =9‐(pyridin‐4‐yl)‐ 9H ‐carbazole‐3,6‐dicarboxylic acid, DMF =N ,N ‐dimethylformamide] was synthesized under solvothermal condition. Crystal structural analysis reveals that CdL features the layered 2D framework with L^{2 −} ligands as 3‐connected nodes. The compound CdL emits blue‐violet light with the narrow emission peak and the emission maximum at 414 nm upon excitation at the maximum excitation wavelength of 340 nm. The compound CdL has a similar emission spectrum curve to the free H₂L ligand that indicates the emission of compound CdL should be originated from the coordinated L^{2 −} ligands.     

Design,Synthesis, and Evaluation of 3‐((4‐(t‐Butyl)‐2‐(2‐benzylidenehydrazinyl)thiazol‐5‐yl)methyl)quinolin‐2(1H)‐ones as Neuraminidase Inhibitors

A series of novel 3‐((4‐(t‐butyl)‐2‐(2‐benzylidenehydrazinyl)thiazol‐5‐yl)methyl)quinolin‐2(1H)‐ones ( 7a – 7z ) were designed, synthesized and evaluated for their ability of inhibiting neuraminidase (NA) of in?uenza H1N1 virus. Some compounds displayed moderate influenza NA inhibitory activity. Compound 7l with the scaffold of 2‐(2‐(2‐methoxybenzylidene)hydrazinyl)thiazole was the best one, exhibiting moderate NA inhibitory activity with IC₅₀ of 44.66 µmol/L. Structure‐activity relationship showed that compounds with methoxy or hydroxy groups at the ortho position, fluorine and nitro groups at the meta position and chlorine and bromine groups at the para position of phenyl ring were more active. Docking study indicated that compound 7l has important interactions with some key residues (including Asp151, Glu119, Arg292, Tyr406, and Asn347) and binds to 430‐cavity adjacent to NA active site.     

高效液相色谱法测定大鼠血浆中芳香异羟肟酸二丁基锡的含量以及它在动力学研究中的应用

[(n-Bu)2Sn[{4-ClC6H4C(O)NHO}2] (DBDCT) 是课题组自主设计合成的一种新型芳香异羟肟酸二丁基锡化合物(已获国际国内发明专利),有较高的体内和体外抗肿瘤活性,小鼠急毒实验揭示其具有较低的毒性作用,初步动物实验提示DBDCT还具有升高白细胞的功能,在肿瘤化疗治疗中将产生重要的影响。本文首次建立了HPLC法测定化合物在血浆中的动力学参数。用甲醇直接沉淀血浆蛋白,乙酰苯胺为内标, Diamonsil ODS（4.6 mm × 200 mm, 5 μm）色谱柱,甲醇:0.5%三氟乙酸水溶液（30:70,pH 3.0,v/v）为流动相,检测波长238 nm。方法在0.1～25 µg·mLl-1范围内线性关系良好(r = 0.9992),定量限和检测限分别为50 和10 ng·mL-1。该方法用来测定单次静脉注射不同剂量(2,5,12mg·kg-1) DBDCT后大鼠体内的浓度-时间曲线,并采用3p97软件对动力学参数和房室模型进行估计,结果表明DBDCT在大鼠体内的动力学符合二室模型,方法简便快速,专属性好,其动力学研究中的应用为制剂的质量控制和临床前动物合理用药以及临床研究提供了实验基础。     

Antioxidative vs cytotoxic activities of organotin complexes bearing 2,6‐di‐tert‐butylphenol moieties

Two series of organotin(IV) complexes with Sn–S bonds on the base of 2,6‐di‐tert‐butyl‐4‐mercaptophenol ( L ¹ SH ) of formulae Me₂Sn(L¹S)₂ ( 1 ); Et₂Sn(L¹S)₂ ( 2 ); Bu₂Sn(L¹S)₂ ( 3 ); Ph ₂ Sn(L¹S)₂ ( 4 ); (L¹)₂Sn(L¹S)₂ ( 5 ); Me₃Sn(L¹S) ( 6 ); Ph₃Sn(L¹S) ( 7 ) (L¹ = 3,5‐di‐tert‐butyl‐4‐hydroxyphenyl), together with the new ones [Me₃SnCl(L²)] ( 8 ), [Me₂SnCl₂(L²)₂] ( 9 ) ( L ²  = 2‐(N‐3′,5′‐di‐tert‐butyl‐4′‐hydroxyphenyl)‐iminomethylphenol) were used to study their antioxidant and cytotoxic activity. Novel complexes 8 , 9 of Me_nSnCl_4 ? n (n = 3, 2) with Schiff base were synthesized and characterized by ¹H, ¹³C NMR, IR and elemental analysis. The crystal structures of compounds 8 and 9 were determined by X‐ray diffraction analysis. The distorted tetrahedral geometry around the Sn center in the monocrystals of 8 was revealed, the Schiff base is coordinated to the tin(IV) atom by electrostatic interaction and formation of short contact Sn–O 2.805 Å. In the case of complex 9 the distorted octahedron coordination of Sn atom is formed. The antioxidant activity of compounds as radical scavengers and reducing agents was proved spectrophotometrically in tests with stable radical DPPH, reduction of Cu²⁺ (CUPRAC method) and interaction with superoxide radical‐anion. Moreover, compounds have been screened for in vitro cytotoxicity on eight human cancer cell lines. A high activity against all cell lines with IC₅₀ values 60–160 nM was determined for the triphenyltin complex 7 , while the introduction of Schiff base decreased the cytotoxicity of the complexes. The influence on mitochondrial potential and mitochondrial permeability for the compounds 8 and 9 has been studied. It is shown that studied complexes depolarize the mitochondria but don't influence the calcium‐induced mitochondrial permeability transition.     

Synthesis,characterization and in vitro antitumour activity of di‐ and tri‐organotin derivatives of fenbufen

The di‐ and tri‐organotin derivatives of fenbufen (4‐(4‐biphenyl)‐4‐oxobutyric acid), [{(n‐C₄H₉)₂Sn(OCOCH₂CH₂COC₆H₄C₆H₅‐4)}₂O]₂ ( 1 ) and R₃SnOCOCH₂CH₂COC₆H₄C₆H₅‐4 (R?C₆H₅, 2 ; c‐C₆H₁₁, 3 ; C₆H₅C(CH₃)₂CH₂, 4 ), have been prepared and characterized by means of elemental analysis, IR and NMR (¹H, ¹³C and ¹¹⁹Sn) spectroscopies. The crystal structure of 1 , bis[4‐(4‐biphenyl)‐4‐oxobutyrato]tetra‐n‐butyldistannoxane, has been determined and it is a centrosymmetric dimer with two distinct types of carboxylate moieties and tin atoms with distorted trigonal bipyramidal geometries. The in vitro antitumour activity of 1 and 2 against two human tumour cell lines was found to be higher than that for cis‐platin used clinically. Copyright © 2005 John Wiley & Sons, Ltd.     

Mononuclear Co(III), Ni(II) and Cu(II) complexes of tridentate di‐tert‐butylphenylhydrazone: Synthesis,characterization, X‐ray crystal structures,Hirshfeld surface analysis,molecular docking and in vivo anti‐inflammatory activity

A new hydrazone (LH₂) derived from the condensation of 2‐(4‐fluorobenzamido)benzohydrazide with 3,5‐di‐tert‐butyl‐2‐hydroxybenzaldehyde was used to synthesize Co(III), Ni(II) and Cu(II) complexes. These were characterized using various physicochemical, thermal, spectroscopic and single‐crystal X‐ray diffraction techniques. All the complexes crystallize in a monoclinic crystal system with P2₁/n space group and Z = 4. Structural studies of [Co(L)(LH)]?H₂O indicate the presence of both amido and imidol tautomeric forms of the ligand, resulting in a distorted octahedral geometry around the Co(III) ion. On the other hand, in the [Ni(L)(DMF)] and [Cu(L)(H₂O)] complexes, the ligand coordinates to the metal through imidol form resulting in distorted square planar geometry, in which the fourth position is occupied by the oxygen of coordinated DMF in [Ni(L)(DMF)] and by a water molecule in [Cu(L)(H₂O)]. Hirshfeld surface calculations were performed to explore hydrogen bonding and C―H???π interactions. Molecular docking studies were carried out to study the interaction between the synthesized compounds and proteins (cyclooxygenase‐2 and 5‐lipoxygenase). The complexes along with the parent ligand were screened for their in vivo anti‐inflammatory activity, using the carrageenan‐induced rat paw oedema method. The complexes show significant anti‐inflammatory potencies.     

Two Lanthanide(III) Complexes based on the Schiff Base N,N′‐Bis(salicylidene)‐1,5‐diamino‐3‐oxapentane: Synthesis,Characterization, DNA‐binding Properties,and Antioxidation

The Schiff base N,N′‐bis(salicylidene)‐1,5‐diamino‐3‐oxapentane (H₂L) and its lanthanide(III) complexes, PrL(NO₃)(DMF)(H₂O) ( 1 ) and Ho₂L₂(NO₃)₂ · 2H₂O ( 2 ), were synthesized and characterized by physicochemical and spectroscopic methods. Single crystal X‐ray structure analysis revealed that complex 1 is a discrete mononuclear species. The Pr^III ion is nine‐coordinate, forming a distorted capped square antiprismatic arrangement. Complex 2 is a centrosymmetric dinuclear neutral entity in which the Ho^III ion is eight‐coordinate with distorted square antiprismatic arrangement. The DNA‐binding properties of H₂L and its Ln^III complexes were investigated by spectrophotometric methods and viscosity measurements. The results suggest that the ligand H₂L and its Ln^III complexes both connect to DNA in a groove binding mode; the complexes bind more strongly to DNA than the ligand. Moreover, the antioxidant activities of the Ln^III complexes were in vitro determined by superoxide and hydroxyl radical scavenging methods, which indicate that complexes 1 and 2 have OH ^· and O₂^{– ·} radical scavenging activity.     

Synthesis,Structure, and Magnetic Characterization of a Series of Iron(II) Coordination Frameworks with 2, 6‐Bis(1, 2,4‐triazole‐4‐yl)pyridine

Based on the bis‐triazole ligand 2, 6‐bis(1, 2,4‐triazole‐4‐yl)pyridine (L), the triazole‐iron(II) complexes [Fe(L)₂(dca)₂(H₂O)₂] · 2H₂O ( 1 ) (Nadca = sodium dicyanamide), {[Fe(μ₂‐L)₂(H₂O)₂]Cl₂}_n ( 2 ), and {[Fe(μ₂‐L)₂(H₂O)₂](ClO₄)₂ · L · H₂O}_n ( 3 ) were isolated by solvent diffusion methods. When iron(II) salts and Nadca were used, compound 1 was isolated, which contains mononuclear Fe(L)₂(dca)₂(H₂O)₂ units. When FeCl₂ or FeClO₄ were used, one‐dimensional (1D) cation iron(II) chains ( 2 ) and two‐dimensional (2D) cation iron(II) networks ( 3 ) were isolated indicating anion directing structural diversity. Moreover, variable‐temperature magnetic susceptibility data of 1 – 3 were recorded in the temperature range 2–300 K. The magnetic curve of complex 2 was fitted by using the classical spin Heisenberg chain model indicating anti‐ferromagnetic interactions (J = –5.31 cm^–1). Obviously complexes 1 – 3 show no detectable thermal spin crossover behaviors, the lack of spin‐crossover behavior may be correlated with FeN₄O₂ coordination spheres in 1 – 3 .     

Crystallographic report: Di(p‐fluorobenzyl)tin bis(N,N‐dimethyldithiocarbamate)

The tin atom in (p–FC₆H₄CH₂)₂(S₂CNMe)₂ is in a skewed‐trapezoidal bipyramidal geometry defined by two sets of sulfur donors derived from the dithiocarbamate ligands and two carbon atoms from the tin‐bound p‐fluorobenzyl substituents; C? Sn? C is 129.2(2)°. Copyright © 2004 John Wiley & Sons, Ltd.     

DFT study of the structure and spectral behavior of new pt(II) complexes with 5‐methyl‐5(4‐pyridyl)hydantoin

Platinum complexes are a great interest of study, because of the antitumor activity and the clinical use of some of them in the recent anticancer chemotherapy. In many cases, computational studies can be very useful for predicting the structure and some physicochemical properties of metal complexes. Theoretical calculations can also be used for the rational design of new complexes with optimal ratio: antitumor activity/toxicity. The geometry of three new Pt(II) complexes with general formula cis‐[PtL₂X₂] (where L is 5‐methyl‐5(4‐pyridyl)hydantoin and X = Cl^?, Br^?, I^?) and of the free organic ligand were optimized using the hybrid DFT method B3LYP with LAN2DZ basis sets. The results were in very good correlation with the data of similar compounds from the literature. The same DFT method was used for the study of their spectral behavior, by reproducing their IR and Raman spectra and comparing them with experimental data. In addition, the distribution of charges by ESP analysis was calculated. © 2008 Wiley Periodicals, Inc. Int J Quantum Chem, 2009     

Synthesis and characterization of di‐n‐butyltin(IV) complexes with 4′/2′‐nitrobiphenyl‐2‐carboxylic acids: X‐ray crystal structures of [{(n‐C4H9)2Sn(OCOC12H8NO2−4′)}2O]2 and (n‐C4H9)2Sn{OCOC12H8NO2−4′}2

Reactions of di‐n‐butyltin(IV) oxide with 4′/2′‐nitrobiphenyl‐2‐carboxylic acids in 1 : 1 and 1 : 2 stoichiometry yield complexes [{(n‐C₄H₉)₂Sn(OCOC₁₂H₈NO₂?4′/2′)}₂O]₂ ( 1 and 2 ) and (n‐C₄H₉)₂Sn(OCOC₁₂H₈NO₂?4′/2′)₂ ( 3 and 4 ) respectively. These compounds were characterized by elemental analysis, IR and NMR (¹H, ¹³C and ¹¹⁹Sn) spectroscopy. The IR spectra of these compounds indicate the presence of anisobidentate carboxylate groups and non‐linear C? Sn? C bonds. From the chemical shifts δ (¹¹⁹Sn) and the coupling constants ¹J(¹³C, ¹¹⁹Sn), the coordination number of the tin atom and the geometry of its coordination sphere have been suggested. [{(n‐C₄H₉)₂Sn(OCOC₁₂H₈NO₂?4′)}₂O]₂ ( 1 ) exhibits a dimeric structure containing distannoxane units with two types of tin atom with essentially identical geometry. To a first approximation, the tin atoms appear to be pentacoordinated with distorted trigonal bipyramidal geometry. However, each type of tin atom is further subjected to a sixth weaker interaction and may be described as having a capped trigonal bipyramidal structure. The diffraction study of the complex (n‐C₄H₉)₂Sn(OCOC₁₂H₈NO₂?4′)₂ ( 3 ) shows a six–coordinate tin in a distorted octahedral frame containing bidentate asymmetric chelating carboxylate groups, with the n‐Bu groups trans to each other. The n‐Bu? Sn? n‐Bu angle is 152.8° and the Sn? O distances are 2.108(4) and 2.493(5) Å. The oxygen atom of the nitro group of the ligand does not participate in bonding to the tin atom in 1 and 3 . Crystals of 1 are triclinic with space group P1 and of that of 3 have orthorhombic space group Pnna. Copyright © 2003 John Wiley & Sons, Ltd.     

Synthesis,X‐ray powder structure analysis and biological properties of a mononuclear Cu(II) complex of N‐2‐hydroxyhippuric acid

A mononuclear copper (II) complex of N‐2‐hydroxyhippuric acid (2HHA), [Cu(HA)(H₂O)₂], has been synthesized and characterized by spectroscopic and X‐ray powder diffraction studies. Crystal structure of [Cu(HA)(H₂O)₂] reveals a distorted square‐pyramidal geometry around the metal center. The crystal packing in the complex exhibits a three‐dimensional framework formed by intermolecular O? ; H···O and C? H···O hydrogen bonds. Toxicity and antitumor properties of the complex have been studied in vivo. The complex, capable of depleting glutathione (GSH) at nontoxic doses, may be utilized to sensitize drug‐resistant cells where resistance is due to an elevated level of GSH. Copyright © 2009 John Wiley & Sons, Ltd.     

The exopolyhedral ligand orientation (ELO) in 3‐(nitrato‐κO)‐3,3‐bis(triphenylphosphane‐κP)‐3‐rhoda‐1,2‐dicarba‐closo‐dodecaborane(11) dichloromethane 2.2‐solvate

In the title compound, [Rh(C₂H₁₁B₉)(NO₃)(C₁₈H₁₅P)₂]·2.2CH₂Cl₂, studied as a 2.2‐solvate of what was assumed to be dichloromethane, the nitrate ligand lies cis with respect to both cage C atoms. Accordingly, the compound displays a pronounced preferred exopolyhedral ligand orientation (ELO) which is traced to both the greater trans influence of the cage B over the cage C atoms and the greater trans influence of the triphenylphosphane ligands over the nitrate ligand. The overall molecular architecture therefore agrees with that of a number of similar 3‐L‐3,3‐L′₂‐3,1,2‐closo‐MC₂B₉H₁₁ species in the literature.     

DFT Calculations,Spectroscopic Studies,Biological Activity and Non Linear Optical Properties (NLO) of Novel Ternary Cu(II)‐Chelates Derived from 5‐Acetyl‐4‐hydroxy‐2H‐1,3‐thiazinedione

New ternary Cu(II)‐chelates with the general formula [ML L′(H₂O)_x] (NO₃)_y x (H₂O), x = 0–2 and y = 0–1, (L) = 5‐acetyl‐4‐hydroxy‐2H‐1,3‐thiazine‐2,6(3H)‐dione with in the presence of a secondary ligand (L′) [N,O‐donor; 8 hydroxyquinoline or N,N‐donor; 1,10‐phenanthroline and diethethylendiamine]. Characterization of the synthesized complexes was established based on elemental analysis, molar conductance, magnetic susceptibility measurements, spectral (infrared, electronic, mass, ¹H‐NMR and ESR) as well as thermal gravimetric analysis (TGA). The complexes exhibited octahedral and square planer geometry. The antimicrobial activity for the studied complexes was tested for different kind of organisms. The geometrical and non‐linear optical parameters of the studied complexes 1–3 are investigated theoretically at the B3LYP/GENECP level of theory. The optimized geometries of the studied complexes are non‐planner as indicated from the dihedral angles. The natural charge population (core, valence and Rydberg), exact electronic configuration, total Lewis, and total non‐Lewis is computed and discussed in terms of natural bond orbitals (NBO) analysis. The calculated E_HOMO and E_LUMO energies at the same level of theory of the studied complexes were used to calculate the global properties; hardness (η), global softness (S), electrophilicity (ω) and electronegativity (χ). The total dipole moment (μ_tot), total and anisotropy of polarizability (? α ?), (Δα) and first hyperpolarizability (? β ?) values were calculated and compared with urea as a reference compound. From the values of the computed first hyperpolarizability (? β ?), the ligand and the studied complexes show promising optical properties.     

Novel drug‐based Fe(III) heterochelates: synthetic,spectroscopic, thermal and in‐vitro antibacterial significance

A series of novel heterochelates of the type [Fe(Aⁿ)(L)(H₂O)₂]^?mH₂O [where H₂Aⁿ = 4,4′‐(arylmethylene)bis(3‐methyl‐1‐phenyl‐4,5‐dihydro‐1H‐pyrazol‐5‐ol); aryl = 4‐nitrophenyl, m = 1 (H₂A¹); 4‐chlorophenyl, m = 2 (H₂A²); phenyl, m = 2 (H₂A³); 4‐hydroxyphenyl, m = 2 (H₂A⁴); 4‐methoxyphenyl, m = 2 (H₂A⁵); 4‐hydroxy‐3‐methoxyphenyl, m = 1.5 (H₂A⁶); 2‐nitrophenyl, m = 1.5 (H₂A⁷); 3‐nitrophenyl, m = 0.5 (H₂A⁸); p‐tolyl, m = 1 (H₂A⁹) and HL = 1‐cyclopropyl‐6‐fluoro‐4‐oxo‐7‐(piperazin‐1‐yl)‐1,4‐dihydroquinoline‐3‐carboxylic acid] were investigated. They were characterized by elemental analysis (FT‐IR, ¹H‐ & ¹³C‐NMR, and electronic) spectra, magnetic measurements and thermal studies. The FAB‐mass spectrum of [Fe(A³)(L)(H₂O)₂]^?2H₂O was determined. Magnetic moment and reflectance spectral studies revealed that an octahedral geometry could be assigned to all the prepared heterochelates. Ligands (H₂Aⁿ) and their heterochelates were screened for their in‐vitro antibacterial activity against Bacillus subtilis, Staphylococcus aureus, Escherichia coli and Serratia marcescens bacterial strains. The kinetic parameters such as order of reaction (n), the energy of activation (E_a), the pre‐exponential factor (A), the activation entropy (ΔS^#), the activation enthalpy (ΔH^#) and the free energy of activation (ΔG^#) are reported. Copyright © 2009 John Wiley & Sons, Ltd.     

Factors influencing the electroreductive polymerization of di‐n‐hexyldichlorosilane

This paper reports the study of the effects of solvent, support electrolyte and the nature of the electrodes on the electroreduction of di‐n‐hexyldichlorosilane. The work performed involved the use of different types of sacrificial anode (magnesium, aluminium and zinc) and cathode (magnesium, aluminium, zinc, stainless steel, nickel, carbon and palladium) in tetrahydrofuran containing lithium perchlorate (LiClO₄). Monomodal poly(di‐n‐hexyldichlorosilane) was obtained with Al/Al and Mg/Mg electrode pairs, but the polymer yield was about ten times higher with Al/Al (11%) than with Mg/Mg (1%). From the solvents and co‐solvents used (tetrahydrofuran, hexamethylphosphorotriamide, acetone, hexane, toluene, 1,1,3,3‐tetramethylurea, tris(3,6‐dioxaheptyl)amine, 1,2‐dimethoxyethane, N,N‐dimethylacetamide and dimethylformamide) with LiClO₄, only the system tetrahydrofuran + hexamethylphosphorotriamide, tetrahydrofuran + N,N‐dimethylacetamide and tetrahydrofuran + toluene have given monomodal poly(di‐n‐hexyldichlorosilane) using an aluminium anode and stainless‐steel cathode. Copyright © 2001 John Wiley & Sons, Ltd.     

Synthesis,in vitro Antimicrobial,and Cytotoxic Activities of New 1,3,4‐Oxadiazin‐5(6H)‐one Derivatives from Dehydroabietic Acid

A series of new 1,3,4‐oxadiazin‐5(6H)‐one derivatives ( 6a–n ) of dehydroabietic acid were designed and synthesized as potential antimicrobial and antitumor agents. Their structures were characterized by IR, ¹H NMR, ¹³C NMR, MS, and elemental analyses. All the title compounds were evaluated for their antimicrobial activity against four bacterial and three fungal strains using the serial dilution method. Among them, compound 6e showed the highest antibacterial activity against Bacillus subtilis with a minimum inhibitory concentration (MIC) value of 1.9 μg/mL. In addition, the in vitro cytotoxic activities of the title compounds were also assayed against three human carcinoma cell lines (MCF‐7, SMMC‐7721, and HeLa) through the MTT colorimetric method. As a result, compounds 6b , 6g , 6k, and 6m exhibited significant inhibition against at least one cell line with IC₅₀ values below 10 μM. Compound 6m was especially found to be the most potent derivative with IC₅₀ values of 2.26 ± 0.23, 0.97 ± 0.11, and 1.89 ± 0.31 μM against MCF‐7, SMMC‐7721, and HeLa cells, respectively, comparable to positive control etoposide.     

Synthesis,spectroscopic, thermal and biological aspects of drug‐based copper(II) complexes

A series of novel complexes of the type Cu(II)(L_n)₂(H₂O)₂]^•xH₂O [where L_n = L _1–4 , these ligands being described as: L ₁ , 2‐({4‐[6,7‐dihydrothieno[3,2‐c]pyridin‐5(4H)‐ylsulfonyl]phenylimino}methyl)phenol, x = 1; L ₂ , 2‐({4‐[6,7‐dihydrothieno[3,2‐c] pyridin‐5(4H)‐ylsulfonyl]phenylimino}methyl)‐5‐(methoxy)phenol, x = 2; L ₃ , 5‐chloro‐2‐({4‐[6,7‐dihydrothieno[3,2‐c]pyridin‐5(4H)‐ylsulfonyl]phenylimino}methyl)phenol, x = 2; and L ₄ , 5‐bromo‐4‐chloro‐2‐({4‐[6,7‐dihydrothieno[3,2‐c]pyridin‐5(4H)‐ylsulfonyl]phenylimino} methyl)phenol, x = 1] was investigated. They were characterized by elemental analysis, IR, ¹H‐NMR, ¹³C‐NMR and electronic spectra, magnetic measurements and thermal studies. The FAB‐mass spectrum of [Cu(II)( L ₁ )₂(H₂O)₂]^•H₂O was determined. A magnetic moment and reflectance spectral study revealed that an octahedral geometry could be assigned to all the prepared complexes. Ligands (L_n) and their metal complexes were screened for their in vitro antibacterial activity against Bacillus subtillis, Pseudomonas aeruginosa, Escherichia coli and Serratia marcescens bacterial strains. Kinetic parameters such as order of reaction (n), the energy of activation (E_a), the pre‐exponential factor (A), the activation entropy (ΔS^≠), the activation enthalpy (ΔH^≠) and the free energy of activation (ΔG^≠) are reported. Copyright © 2011 John Wiley & Sons, Ltd.     

A new heteroleptic oxalate‐based compound: poly[[2‐(aminomethyl)pyridine]di‐μ6‐oxalato‐chromium(III)potassium(I)]

The title compound, [KCr(C₂O₂)₂(C₆H₈N₂)]_n, was obtained from aqueous solution and analyzed with single‐crystal X‐ray diffraction at 100 K. It crystallizes in the monoclinic space group C2/c and displays a three‐dimensional polymeric architecture built up by bimetallic oxalate‐bridged Cr^III–K helical chains linked through centrosymmetric K₂O₂ units to yield a sheet‐like alternating P/M arrangement which looks like that of the previously described two‐dimensional [NaCr(ox)₂(pyim)(H₂O)]·2H₂O [pyim is 2‐(pyridin‐2‐yl)imidazole; Lei et al. (2006). Inorg. Chem. Commun. 9 , 486–488]. The Cr^III ions in each helix have the same chirality. The infinite neutral sheets are eclipsed with respect to each other and are held together by a hydrogen‐bonding network involving 2‐(aminomethyl)pyridine H atoms and oxalate O atoms. Each sheet gives rise to channels of Cr₄K₄ octanuclear rings and each resultant hole is occupied by a pair of 2‐(aminomethyl)pyridine ligands with partial overlap. The shortest Cr...Cr distance [5.593 (4) Å] is shorter than usually observed in the K–M^III–oxalate family.